Lucy Scientific Discovery, Inc. financial data

Symbol
LSDIF on OTC
Industry
Pharmaceutical Preparations
Location
301 1321 Blanshard Street, Victoria, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
June 30
Latest financial report
10-Q - Q4 2023 - Feb 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 120 %
Debt-to-equity 114 %
Return On Equity -337 % -434%
Return On Assets -157 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.6M shares
Common Stock, Shares, Outstanding 17.6M shares +69%
Common Stock, Value, Issued 49M USD +59.2%
Weighted Average Number of Shares Outstanding, Basic 17.6M shares +69%
Weighted Average Number of Shares Outstanding, Diluted 17.6M shares +69%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.68K USD
Operating Income (Loss) -1.61M USD -94%
Nonoperating Income (Expense) -2.95M USD +9.08%
Net Income (Loss) Attributable to Parent -11.3M USD -114%
Earnings Per Share, Basic -0.74 USD/shares -55.6%
Earnings Per Share, Diluted -0.69 USD/shares +15.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 238K USD
Accounts Receivable, after Allowance for Credit Loss, Current 642 USD
Assets, Current 1.34M USD -8.73%
Property, Plant and Equipment, Net 668K USD
Operating Lease, Right-of-Use Asset 976K USD
Intangible Assets, Net (Excluding Goodwill) 1.45M USD
Assets 4.29M USD -10.3%
Accrued Liabilities, Current 36K USD -77.7%
Liabilities, Current 3.49M USD -60.2%
Operating Lease, Liability, Noncurrent 1.39M USD +143%
Liabilities 4.21M USD -63.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 81.8K USD
Retained Earnings (Accumulated Deficit) -49M USD -29.9%
Stockholders' Equity Attributable to Parent 81.2K USD
Liabilities and Equity 4.29M USD -10.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.29M USD -423%
Net Cash Provided by (Used in) Investing Activities -123K USD -461%
Common Stock, Shares, Issued 17.6M shares +69%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.44M USD -3784%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 211K USD +710%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.41K USD
Deferred Tax Assets, Valuation Allowance 6.52M USD +25.2%
Deferred Tax Assets, Gross 7.22M USD +33.2%
Operating Lease, Liability 1.68M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -11.4M USD -153%
Lessee, Operating Lease, Liability, to be Paid 3.06M USD
Property, Plant and Equipment, Gross 765K USD -9.35%
Operating Lease, Liability, Current 340K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 369K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 250K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.38M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 409K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.81M USD +35.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 430K USD
Amortization of Intangible Assets 19.2K USD
Interest Expense 1.46M USD -73.5%